Results 231 to 240 of about 15,545,883 (264)

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

open access: yesMolecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi   +6 more
wiley   +1 more source

Optimising clinical trial design choices in inflammatory bowel disease. [PDF]

open access: yesBMJ Open Gastroenterol
Bossuyt P   +4 more
europepmc   +1 more source

Co-design of a digital health intervention to provide pharmacy-based, person-centered contraceptive decision support for youth in Kenya. [PDF]

open access: yesPLOS Glob Public Health
Harrington EK   +9 more
europepmc   +1 more source

Management of choking in Motor Neuron Disease: patient and public involvement in a co-produced mixed-methods study protocol. [PDF]

open access: yesRes Involv Engagem
Moffatt D   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy